Cargando…

Reply to Weinberger

Detalles Bibliográficos
Autores principales:	Birring, Surinder S., Morice, Alyn H., Dicpinigaitis, Peter V., McGarvey, Lorcan P., Pavord, Ian D., Green, Stuart A., Philip, George, Smith, Jaclyn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273115/ https://www.ncbi.nlm.nih.gov/pubmed/37104844 http://dx.doi.org/10.1164/rccm.202304-0709LE

Ejemplares similares

Chronic cough: new insights and future prospects
por: Morice, Alyn, et al.
Publicado: (2021)

Treating acute cough: wet versus dry – have we got the paradigm wrong?
por: Morice, Alyn H., et al.
Publicado: (2015)

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks
por: Birring, Surinder S., et al.
Publicado: (2023)

The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study
por: Smith, Jaclyn A., et al.
Publicado: (2019)

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
por: Muccino, David R., et al.
Publicado: (2020)

Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups
por: Smith, Jaclyn A., et al.
Publicado: (2022)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
por: McGarvey, Lorcan, et al.
Publicado: (2022)

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
por: Morice, Alyn, et al.
Publicado: (2021)

Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
por: Morice, Alyn H., et al.
Publicado: (2021)

From bench to bedside: The role of cough hypersensitivity in chronic cough
por: Drake, Matthew G., et al.
Publicado: (2023)

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study
por: Dicpinigaitis, Peter V., et al.
Publicado: (2023)

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough
por: Ludbrook, Valerie J., et al.
Publicado: (2021)

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
por: Friedrich, Christian, et al.
Publicado: (2023)

An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma
por: Holmes, Joshua, et al.
Publicado: (2022)

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
por: Couillard, Simon, et al.
Publicado: (2021)

Cough hypersensitivity and chronic cough
por: Chung, Kian Fan, et al.
Publicado: (2022)

Reply to: Challenging the paradigm
por: Bush, Andrew, et al.
Publicado: (2022)

Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses
por: Song, Woo-Jung, et al.
Publicado: (2021)

Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study
por: Song, Woo-Jung, et al.
Publicado: (2023)

Burden of chronic cough in the UK: results from the 2018 National Health and Wellness Survey
por: McGarvey, Lorcan, et al.
Publicado: (2023)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Anatomy and Neurophysiology of Cough: CHEST Guideline and Expert Panel Report
por: Canning, Brendan J., et al.
Publicado: (2014)

Recent progress in the management of chronic cough
por: Song, Woo-Jung, et al.
Publicado: (2020)

A Reply to Captain Barnardo's Letter
por: Green-Armytage, V. B.
Publicado: (1914)

Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute)
por: Yousaf, Nadia, et al.
Publicado: (2011)

COUGH: consolidating a mature field for the next 5 years
por: Chung, Kian Fan, et al.
Publicado: (2011)

Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives
por: van Haarst, Aernout, et al.
Publicado: (2019)

Clinical Research Fellow
por: Addy, Charlotte, et al.
Publicado: (2019)

Reply
por: Patel, Yogin, et al.
Publicado: (2020)

Author reply
por: Graham, Philip
Publicado: (2018)

Author reply
por: Graham, Philip
Publicado: (2018)

Reply to Eisenhut
por: Muenchhoff, Maximilian, et al.
Publicado: (2015)

Reply
por: Vowles, Kevin E., et al.
Publicado: (2015)

Author's Reply
por: Hoyt, Brian S, et al.
Publicado: (2014)

Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature
por: Holmes, Joshua, et al.
Publicado: (2022)

Weinberg, Salam and Glashow on physics
Publicado: (1980)

Probing the Weinberg Operator at Colliders
por: Fuks, Benjamin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8d7ppegu05l3h9d5phqbfgf181